Atricure Stock Investor Sentiment
| ATRC Stock | USD 30.54 0.76 2.43% |
About 63% of AtriCure's investor base is looking to short. The analysis of overall sentiment of trading AtriCure stock suggests that many investors are alarmed at this time. The current market sentiment, together with AtriCure's historical and current headlines, can help investors time the market. In addition, many technical investors use AtriCure stock news signals to limit their universe of possible portfolio assets.
Comfort Level 37
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use AtriCure's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward AtriCure.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentDisposing |
AtriCure Historical Sentiment
Although AtriCure's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding AtriCure, such as negative comments on social media and news outlets, may cause fear in the market and push AtriCure's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of AtriCure.
AtriCure Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards AtriCure can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
AtriCure Historical Investor Sentiment
Investor biases related to AtriCure's public news can be used to forecast risks associated with an investment in AtriCure. The trend in average sentiment can be used to explain how an investor holding AtriCure can time the market purely based on public headlines and social activities around AtriCure. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
AtriCure's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for AtriCure and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average AtriCure news discussions. The higher the estimate score, the more favorable the investor's outlook on AtriCure.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of AtriCure's Stock prices. Below is the latest headlines and news related to AtriCure Stock. Current markets are slightly bearish. About 55% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about AtriCure that are available to investors today. This information is accessible both publicly - through AtriCure's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of AtriCure-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of AtriCure news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AtriCure relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AtriCure's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AtriCure alpha.
AtriCure Largest EPS Surprises
Earnings surprises can significantly impact AtriCure's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2013-08-01 | 2013-06-30 | -0.1 | -0.09 | 0.01 | 10 | ||
2012-08-02 | 2012-06-30 | -0.07 | -0.08 | -0.01 | 14 | ||
2011-11-01 | 2011-09-30 | -0.08 | -0.07 | 0.01 | 12 | ||
2011-08-02 | 2011-06-30 | -0.05 | -0.06 | -0.01 | 20 | ||
2011-05-04 | 2011-03-31 | -0.07 | -0.08 | -0.01 | 14 | ||
2024-10-29 | 2024-09-30 | -0.19 | -0.17 | 0.02 | 10 |
There is far too much social signal, news, headlines, and media speculation about AtriCure that are available to investors today. This information is accessible both publicly - through AtriCure's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of AtriCure-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of AtriCure news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AtriCure relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AtriCure's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AtriCure alpha.
AtriCure Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Canada Pension Plan Investment Board Boosts Stock Position in AtriCure, Inc. | 04/25/2025 |
2 | AtriCure, Inc. Q1 2025 Earnings Call Transcript | 05/01/2025 |
3 | Disposition of 585 shares by Justin Noznesky of AtriCure subject to Rule 16b-3 | 05/16/2025 |
4 | Acquisition by Groves Regina E of 5401 shares of AtriCure subject to Rule 16b-3 | 05/19/2025 |
5 | AtriCure Inc to Participate in Goldman Sachs 46th Annual Global Healthcare Conference ... | 05/23/2025 |
6 | Is Astellas Pharma Stock Outpacing Its Medical Peers This Year | 05/27/2025 |
7 | Disposition of 2500 shares by Vinayak Doraiswamy of AtriCure at 33.44 subject to Rule 16b-3 | 05/28/2025 |
8 | AtriCure, Inc. Stock Analysis Strong Buy Ratings and 46.73 percent Potential Upside in Healthcare Sector - DirectorsTalk Interviews | 06/03/2025 |
9 | Acquisition by Privitera Salvatore of 22586 shares of AtriCure subject to Rule 16b-3 | 06/05/2025 |
10 | Are Medical Stocks Lagging Astellas Pharma This Year | 06/12/2025 |
11 | Acquisition by Dahlquist Karl S. of 19359 shares of AtriCure subject to Rule 16b-3 | 06/25/2025 |
12 | AtriCure Profits And Operating Leverage Are Needed Here - Seeking Alpha | 06/26/2025 |
13 | AtriCure Inc Announces Upcoming Release of Q2 2025 Financial Results ATRC stock news | 07/08/2025 |
14 | AtriCure completes enrollment in stroke prevention trial | 07/15/2025 |
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |